Notice of Knight Therapeutics' Third Quarter 2026 Results Conference Call
Globe Newswire•29/10/2026•07:30 ET
0
Key Highlights
- ➤Knight Therapeutics (GUD) reports Q3 2026 results November 5 before market open
- ➤Conference call and webcast scheduled for 8:30 a.m. ET November 5
- ➤Knight operates pharmaceutical subsidiaries across Canada and Latin America
MONTREAL, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-US) pharmaceutical company, will release its third quarter 2026 financial results on Thursday, November 5, 2026 prior to market opening. Following the release, Knight will hold a conference call and audio webcast. Knight cordially invites all interested parties to participate in this call.
Telephone: Toll Free: 1-888-699-1199 or International 1-416-945-7677
Get started
Create a free account to read the full story.